Abstract
Medical devices are a vital part of the global healthcare system that can have far-reaching impact on patient treatment. Therefore, they must be sterile to ensure the patient safety. The prevalent microorganism′s type on a medical device, also known as ′bioburden&rdquo′, is a useful indicator of a potential contamination source. Indeed, bioburden is a potential risk to the patient not only because the sterilization process might not be completely effective, but also post-processing because of the possible presence of residual materials. Although bioburden may be confidently killed by destructive sterilization processes, its proliferation before sterilization should be avoided. For the bioburden determination, culture media and incubation conditions must be carefully selected. Culture media is of fundamental importance for most microbiological tests: to obtain pure cultures, to grow and count microbial cells, and to cultivate and select microorganisms. A culture medium is essentially composed of basic elements (water, nutrients), to which must be added different growth factors that will be specific to each bacterium and necessary for their growth. Without high-quality media, the possibility of achieving accurate, reproducible, and repeatable microbiological test results is reduced. In the ISO 11737-1 (2018) ′Sterilization of health care products- Microbiological methods- Part 1: determination of a population of microorganisms on products′, methods for the determination and microbial characterization of bioburden are proposed. However, few guidelines are given as to culture media other than examples and incubation times. Several studies show that other culture media can also be effective, such as Plate count Agar (PCA). The purpose of this review was to focus on parameters which can have an impact on the bioburden evaluation, specifically the culture media type for the microorganism′s detection in medical devices. Experimentations conducted in our laboratories showed that Plate Count Agar appeared to be a medium of primary importance for the detection of bioburden on medical devices, this media also respecting the 3R's rule.
- Received July 1, 2021.
- Accepted July 22, 2022.
- Copyright © 2022, Parenteral Drug Association
PDA members receive access to all articles published in the current year and previous volume year. Institutional subscribers received access to all content. Log in below to receive access to this article if you are either of these.
If you are neither or you are a PDA member trying to access an article outside of your membership license, then you must purchase access to this article (below). If you do not have a username or password for JPST, you will be required to create an account prior to purchasing.
Full issue PDFs are for PDA members only.
Note to pda.org users
The PDA and PDA bookstore websites (www.pda.org and www.pda.org/bookstore) are separate websites from the PDA JPST website. When you first join PDA, your initial UserID and Password are sent to HighWirePress to create your PDA JPST account. Subsequent UserrID and Password changes required at the PDA websites will not pass on to PDA JPST and vice versa. If you forget your PDA JPST UserID and/or Password, you can request help to retrieve UserID and reset Password below.